Plasmodium falciparum Falcipain-2a Polymorphisms in Southeast Asia and Their Association With Artemisinin Resistance

Background Falcipain-2a ([FP2a] PF3D7_1115700) is a Plasmodium falciparum cysteine protease and hemoglobinase. Functional FP2a is required for potent activity of artemisinin, and in vitro selection for artemisinin resistance selected for an FP2a nonsense mutation. Methods To investigate associations between FP2a polymorphisms and artemisinin resistance and to characterize the diversity of the enzyme in parasites from the China-Myanmar border, we sequenced the full-length FP2a gene in 140 P falciparum isolates collected during 2004-2011. Results The isolates were grouped into 8 different haplotype groups. Haplotype group I appeared in samples obtained after 2008, coinciding with implementation of artemisinin-based combination therapy in this region. In functional studies, compared with wild-type parasites, the FP2a haplotypes demonstrated increased ring survival, and all haplotype groups exhibited significantly reduced FP2a activity, with group I showing the slowest protease kinetics and reduced parasite fitness. Conclusions These results suggest that altered hemoglobin digestion due to FP2a mutations may contribute to artemisinin resistance.

[1]  S. Schaffner,et al.  Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia , 2017, Malaria Journal.

[2]  Mehul Dhorda,et al.  The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study , 2017, The Lancet. Infectious diseases.

[3]  D. Fidock,et al.  A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study , 2017, The Lancet. Infectious diseases.

[4]  D. Kwiatkowski,et al.  Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study. , 2017, The Lancet. Infectious diseases.

[5]  L. Cui,et al.  Limited genetic diversity in the PvK12 Kelch protein in Plasmodium vivax isolates from Southeast Asia , 2016, Malaria Journal.

[6]  X. Su,et al.  Genome-wide association analysis identifies genetic loci associated with resistance to multiple antimalarials in Plasmodium falciparum from China-Myanmar border , 2016, Scientific Reports.

[7]  L. Tilley,et al.  Haemoglobin degradation underpins the sensitivity of early ring stage Plasmodium falciparum to artemisinins , 2016, Journal of Cell Science.

[8]  Saorin Kim,et al.  Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations , 2015, BMC Medicine.

[9]  L. Cui,et al.  In Vitro Activities of Primaquine-Schizonticide Combinations on Asexual Blood Stages and Gametocytes of Plasmodium falciparum , 2015, Antimicrobial Agents and Chemotherapy.

[10]  S. Meshnick,et al.  Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. , 2015, The Lancet. Infectious diseases.

[11]  L. Cui,et al.  Prevalence of K13-propeller polymorphisms in Plasmodium falciparum from China-Myanmar border in 2007–2012 , 2015, Malaria Journal.

[12]  D. Kyle,et al.  Artemisinin-Resistant Plasmodium falciparum Parasites Exhibit Altered Patterns of Development in Infected Erythrocytes , 2015, Antimicrobial Agents and Chemotherapy.

[13]  Gilean McVean,et al.  Genetic architecture of artemisinin-resistant Plasmodium falciparum , 2015, Nature Genetics.

[14]  Yang Zhang,et al.  The I-TASSER Suite: protein structure and function prediction , 2014, Nature Methods.

[15]  P. Rosenthal,et al.  Polymorphisms in K13 and Falcipain-2 Associated with Artemisinin Resistance Are Not Prevalent in Plasmodium falciparum Isolated from Ugandan Children , 2014, PloS one.

[16]  P. Rosenthal,et al.  Cross-Talk between Malarial Cysteine Proteases and Falstatin: The BC Loop as a Hot-Spot Target , 2014, PloS one.

[17]  Kellen L. Olszewski,et al.  Metabolic QTL Analysis Links Chloroquine Resistance in Plasmodium falciparum to Impaired Hemoglobin Catabolism , 2014, PLoS genetics.

[18]  B. Genton,et al.  A molecular marker of artemisinin-resistant Plasmodium falciparum malaria , 2013, Nature.

[19]  Koichiro Tamura,et al.  MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. , 2013, Molecular biology and evolution.

[20]  Saorin Kim,et al.  Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. , 2013, The Lancet. Infectious diseases.

[21]  L. Cui,et al.  In Vitro Sensitivity of Plasmodium falciparum from China-Myanmar Border Area to Major ACT Drugs and Polymorphisms in Potential Target Genes , 2012, PloS one.

[22]  Leann Tilley,et al.  Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion , 2011, Proceedings of the National Academy of Sciences.

[23]  K. Silamut,et al.  Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.

[24]  A. Sali,et al.  Regulatory Elements within the Prodomain of Falcipain-2, a Cysteine Protease of the Malaria Parasite Plasmodium falciparum , 2009, PloS one.

[25]  P. Rosenthal,et al.  Falcipain Cysteine Proteases Require Bipartite Motifs for Trafficking to the Plasmodium falciparum Food Vacuole* , 2007, Journal of Biological Chemistry.

[26]  M. Bogyo,et al.  Falstatin, a Cysteine Protease Inhibitor of Plasmodium falciparum, Facilitates Erythrocyte Invasion , 2006, PLoS pathogens.

[27]  P. Rosenthal,et al.  Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum. , 2006, Molecular and biochemical parasitology.

[28]  Xu Shen,et al.  Structural and Functional Characterization of Falcipain-2, a Hemoglobinase from the Malarial Parasite Plasmodium falciparum* , 2006, Journal of Biological Chemistry.

[29]  R. Fletterick,et al.  Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Jun Liu,et al.  Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Rosenthal,et al.  The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Vincent Danjean,et al.  On the use of haplotype phylogeny to detect disease susceptibility loci , 2005, BMC Genetics.

[33]  P. Rosenthal,et al.  Biosynthesis, localization, and processing of falcipain cysteine proteases of Plasmodium falciparum. , 2005, Molecular and biochemical parasitology.

[34]  L. Goh,et al.  Homology modeling and mutagenesis analyses of Plasmodium falciparum falcipain 2A: implications for rational drug design. , 2004, Biochemical and biophysical research communications.

[35]  P. Rosenthal,et al.  Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Rosenthal,et al.  Independent Intramolecular Mediators of Folding, Activity, and Inhibition for the Plasmodium falciparum Cysteine Protease Falcipain-2* , 2004, Journal of Biological Chemistry.

[37]  P. Rosenthal,et al.  Folding of the Plasmodium falciparum Cysteine Protease Falcipain-2 Is Mediated by a Chaperone-like Peptide and Not the Prodomain* , 2002, The Journal of Biological Chemistry.

[38]  Ashutosh Kumar Singh,et al.  Characterization of Native and Recombinant Falcipain-2, a Principal Trophozoite Cysteine Protease and Essential Hemoglobinase ofPlasmodium falciparum * , 2000, The Journal of Biological Chemistry.

[39]  P. Rosenthal,et al.  Plasmodium falciparum: inhibitors of lysosomal cysteine proteinases inhibit a trophozoite proteinase and block parasite development. , 1989, Molecular and biochemical parasitology.

[40]  P. Rosenthal,et al.  A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum. , 1988, The Journal of clinical investigation.

[41]  W. Trager,et al.  Human malaria parasites in continuous culture. , 1976, Science.

[42]  R. Fairhurst,et al.  Artemisinin-Resistant Plasmodium falciparum Malaria. , 2016, Microbiology spectrum.